Celtic Catalysts wins at The Irish Times’ InterTradeIreland awards
The Irish Times’ InterTradeIreland awards were held during the week ended March 4th 2011. More than 120 companies entered the competition and 21 of these were shortlisted, before the final winners were selected across the various categories. The shortlist was selected by an initial judging panel before the 21 entrants were invited to make presentations to a final judging panel last month.
The research and development innovation award went to Celtic Catalysts and its work on developing catalysts that allow pharma firms to formulate drug molecules without unwanted or potentially harmful traits. The firm is a UCD spin-out company from the UCD School of Chemistry and Chemical Biology and has its headquarters in NovaUCD. Its portfolio includes several best-in-class hydrogenation catalysts that the Company is now using itself for the manufacture of specialised amino acid components of peptide-type pharmaceuticals.
Speaking at the awards in the Royal Hospital Kilmainham, in Dublin, on Wednesday night, Liam Kavanagh, managing director of The Irish Times, noted that: “The 21 shortlisted finalists demonstrate that, despite enormous obstacles and challenges we face, good ideas can still lead to success. Innovation is alive and well can still flourish on this island. We sometimes get caught up in the finer points of policies and strategies at a national level without appreciating the people who are putting all the fine words into practice. That’s what this event – and indeed our monthly Innovation magazine – is all about.”
John Fitzgerald, vice-chairman of InterTradeIreland, commented: “A very noticeable characteristic of all entries was the extent to which they were market-led and market-focused. Not only are they strong ideas and innovative processes but they are clearly focused on answering the need and demands of the marketplace and supported by admirable business plans.”